VEGFA and neoplasm: Vascular endothelial growth factor (VEGF), a key angiogenic factor, which has been largely studied for its prognostic role as a possible therapeutic target, is also associated with locoregional tumor spread and tumor progression, and can be considered as a prognostic marker and therapy control in patients with pNENs [63,64].